⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Global TDP-43 Antibody Market Outlook and Forecast, 2026-2032 - Market to Reach USD 508.93 Million at 12.03% CAGR as Validated Antibodies, AI-Powered Imaging, and Neurodegenerative Research Create New Growth Opportunities
globenewswire.com
ABBV
ABT
ABM
BIO
BIIB
BMRN
CRSP
DHR
EXAS
GILD
ILMN
INCY
ISRG
JNJ
LULU
MDLZ
MRK
NVS
PFE
REGN
ROST
SNPS
SRPT
STX
TMO
TSLA
VRTX
WDC
Global Cyclic Peptide Library Market Outlook and Forecast, 2026-2032 - AI-Enabled Discovery Fuels 16.32% CAGR Toward USD 9.86 Billion as PeptiDream, Bicycle Therapeutics, Pfizer and Roche Advance Competition
globenewswire.com
PFE
AMGN
AZN
EVTC
MRK
NVS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
accessnewswire.com
NVS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
accessnewswire.com
NVS
Bronstein, Gewirtz & Grossman, LLC Is Investigating Novartis AG (NVS) And Encourages Shareholders to Connect
accessnewswire.com
NVS
Breast Cancer Continues to Impact Communities; Austin Rallies Together to Take Action at Susan G. KomenĀ® Austin MORE THAN PINK Walk
businesswire.com
DELL
BAC
NTRA
LLY
NVS
Global Autoimmune Treatment Market to Reach USD 321.95 Billion by 2034, Driven by Rising Prevalence of Autoimmune Diseases, Growing Adoption of Biologics, and Advances in Precision Medicine Says Maximize Market Research
prnewswire.com
ABBV
JNJ
AMGN
BMY
PFE
NVS
SNY
LLY
AZN
UCB
BIIB
VTRS
GILD
KYMR
Global Multiple Sclerosis Treatment Market to Grow at 5.8% CAGR, Reaching USD 44.45 Billion by 2034 as Advanced Therapies and Disease-Modifying Treatments Gain Momentum, Says Maximize Market Research
prnewswire.com
NVS
BIIB
SNY
MRK
BMY
JNJ
TEVA
VTRS
AMGN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
accessnewswire.com
NVS
Global Autoimmune Disease Therapeutics Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight
globenewswire.com
ABBV
ABCL
AZN
BIIB
BMY
EXEL
GILD
GSK
INCY
LRCX
MRK
NVS
PFE
REGN
SNY
TMO
UCB
VRTX